BioSpace News Archive

Biotech Beach

DermTech Management to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2021 at 4:35 p.m. Eastern Time.

September 8, 2021
·
3 min read
Lone Star Bio

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-102 for the Treatment of Rett Syndrome

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), today announced it will host a virtual key opinion leader (KOL) webinar on TSHA-102 for the treatment of Rett syndrome on Wednesday, September 22, 2021, from 10:00 a.m. to 12:30 p.m. ET.

September 8, 2021
·
2 min read
HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.

September 8, 2021
·
1 min read
Pharm Country

CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)

CytoSorbents Corporation (NASDAQ: CTSO), announces a special Company webinar highlighting the topline results of CytoSorbents’ U.S. CTC Multicenter Registry that demonstrate high survival using CytoSorb® in Critically Ill COVID-19 patients on ECMO, on Monday, September 13, 2021,

September 8, 2021
·
6 min read
Profound Medical to Participate in September 2021 Virtual Investor Conferences

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announce that management will participate in two investor conferences in September.

September 8, 2021
·
3 min read
Genetown

Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in a virtual analyst-led fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

September 8, 2021
·
1 min read
HaemaLogiX raises $10 million to advance multiple myeloma treatments

HaemaLogiX Pty Ltd is pleased to both announce the close of a fully subscribed $10 million placement to sophisticated investors and welcomes Platinum Asset Management as core new institutional investor within its Platinum International Health Care Fund.

September 8, 2021
·
5 min read
Bio NC

The Vaccine Mandate Challenge: Proof of Vaccines, Waivers, and Diagnostic Testing Required

The recent U.S. Food and Drug Administration (FDA) decision to grant full approval to Pfizer’s COVID-19 vaccine is pushing public and private entities to implement widespread vaccine mandates.

September 8, 2021
·
3 min read
Lone Star Bio

Plus Therapeutics to Present at the H.C. Wainwright Global Investment Conference - Sep 08, 2021

Plus Therapeutics, Inc. announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will present a Company overview at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13 – 15, 2021.

September 8, 2021
·
4 min read
Business

Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, announced the appointment of Marc Blaustein as Chief Operating Officer.

September 8, 2021
·
6 min read